European Pressures Will Challenge The Oncology Pipeline While Alliances Cushion
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
13 Jul 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
JP¥4,500.00
20.8% undervalued intrinsic discount23 Jul
JP¥3,566.00
1Y
-34.3%7D
-2.1%